Nano‑calcium phosphate bone cement based on Si-stabilized α-tricalcium phosphate with improved mechanical properties.

07:00 EST 1st December 2017 | BioPortfolio

Summary of "Nano‑calcium phosphate bone cement based on Si-stabilized α-tricalcium phosphate with improved mechanical properties."

This study aimed to develop nano‑calcium phosphate cement (nCPC) and evaluate the effect of nanosized precursors on mechanical, physical and handling properties (injectability and setting time) as well as conversion rate of nano-reactants into nano-hydroxyapatite (nHA). In this study, while alpha tricalcium phosphate (α-TCP, 98wt%) and HA (2wt%) were applied as the powder phase, 2.5wt% NaH2PO4 solution was used as liquid phase of cement. Before nano-CPC preparation, Si-stabilized α-TCP nanopowder with particle size of 10±3.6nm was firstly synthesized in a two-step process of sol-gel followed by mechanical alloying. Moreover, HA nanopowder with particle size of 32±3.6nm was synthesized using sol-gel process. Our results revealed that after 3days of immersion in ringer's solution, reactants almost completely converted to nHA. Moreover, the initial and final setting time of nano-CPC was obtained 6.3±2.1min and 14.3±4.0min, respectively. Furthermore, injectability of this formulation was reached 87.90±2.60%. In addition, our results confirmed that the compressive strength and modulus of nano-CPC enhanced with increasing immersion time in ringer's solution from 9.50±1.27MPa and 0.38±0.07GPa (at 1day) to 18.70±2.23MPa and 0.57±0.15GPa (at 5days), respectively. Finally, in order to evaluate cellular responses to nano-CPC, MG63 cells were cultured on it and cell morphology and cytotoxicity were evaluated. Results revealed that nano-CPC enhanced proliferation and spreading of osteoblast like cells compared to control (tissue culture plate) which could be due to both appropriate physical and chemical properties of nano-CPC which stimulate cell proliferation. Our findings suggest the formation of an injectable nano-CPC with appropriate mechanical, physical and degradation rate which can potentially utilized for filling bone defects.


Journal Details

This article was published in the following journal.

Name: Materials science & engineering. C, Materials for biological applications
ISSN: 1873-0191
Pages: 532-541


DeepDyve research library

PubMed Articles [20589 Associated PubMed Articles listed on BioPortfolio]

Synthesis of β-tricalcium phosphate.

Ceramics play a key role in several biomedical applications. One of them is bone grafting, which is used for treating bone defects caused by injuries or osteoporosis. Calcium-phosphate based ceramic a...

The rheological behavior of a fast-setting calcium phosphate bone cement and its dependence on deformation conditions.

Calcium phosphate cements are osteoconductive biomaterials that are widely used for bone repair and regeneration applications, including spinal fusion, vertebroplasty, khyphoplasty, cranioplasty and p...

In vitro Growth Pattern of Primary Human Osteoblasts on Calcium Phosphate- and Polymethylmethacrylate-Based Bone Cement.

Polymethylmethacrylate (PMMA) and calcium phosphate (Ca-P) cements are widely used for arthroplasty surgery and augmentation of bone defects. However, aseptic implant loosening in absence of wear-indu...

Synergic effect of chitosan and dicalcium phosphate on tricalcium silicate-based nanocomposite for root-end dental application.

In recent years, cement composites based on calcium silicate have been more generally considered for medical applications. Calcium silicate Cement are among the categories that are used in dental root...

An injectable, biodegradable calcium phosphate cement containing poly lactic-co-glycolic acid as a bone substitute in ex vivo human vertebral compression fracture and rabbit bone defect models.

Purpose/Aim of the study: To evaluate the biomechanical characteristics and biocompatibility of an injectable, biodegradable calcium phosphate cement (CPC) containing poly lactic-co-glycolic acid (PLG...

Clinical Trials [6145 Associated Clinical Trials listed on BioPortfolio]

Calcium Phosphate Cement Registry (CPC Registry)

CPC REGISTRY is a multi-center, international, prospective, open-label, observational study on the use of injectable calcium phosphate cements for the treatment of bone defects in adults. ...

Comparison of Bioactive Glass and Beeta-Tricalcium Phosphate as Bone Graft Substitute

This study is designed to perform a head-to-head comparison of two synthetic ceramic bone graft substitutes, bioactive glass (BAG) and beeta-tricalcium phosphate (TCP), in filling of conta...

Comparison of Three Calcium Supplements

The study was conducted to investigate the metabolic effects of three different calcium compounds in healthy adults.

Efficacy and Safety Study of Non-Percutaneous Vertebroplasty With Macroporous Calcium Phosphate Cement (MCPC)

The macroporous calcium phosphate cement, MCPC, which composition is close to bone, is malleable and biocompatible, and has intrinsic radio opacity and good ability to undergo mechanical c...

Polycaprolactone / Tricalcium Phosphate (PCL/TCP) v Titanium Orbital Implant : Randomised Trial

Hypothesis: Polycaprolactone / Tricalcium Phosphate Orbital (PCL / TCP) Implant is as effective in the reconstruction of the Orbital walls as Titanium Mesh implant. In this study we will...

Medical and Biotech [MESH] Definitions

Adhesives used to fix prosthetic devices to bones and to cement bone to bone in difficult fractures. Synthetic resins are commonly used as cements. A mixture of monocalcium phosphate, monohydrate, alpha-tricalcium phosphate, and calcium carbonate with a sodium phosphate solution is also a useful bone paste.

Synthetic or natural materials for the replacement of bones or bone tissue. They include hard tissue replacement polymers, natural coral, hydroxyapatite, beta-tricalcium phosphate, and various other biomaterials. The bone substitutes as inert materials can be incorporated into surrounding tissue or gradually replaced by original tissue.

Long-lasting voltage-gated CALCIUM CHANNELS found in both excitable and nonexcitable tissue. They are responsible for normal myocardial and vascular smooth muscle contractility. Five subunits (alpha-1, alpha-2, beta, gamma, and delta) make up the L-type channel. The alpha-1 subunit is the binding site for calcium-based antagonists. Dihydropyridine-based calcium antagonists are used as markers for these binding sites.

Carbonic acid calcium salt (CaCO3). An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement.

Calcium compounds used as food supplements or in food to supply the body with calcium. Dietary calcium is needed during growth for bone development and for maintenance of skeletal integrity later in life to prevent osteoporosis.

Quick Search

DeepDyve research library

Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Searches Linking to this Article